These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 10512675)
1. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Manda R; Kohno T; Matsuno Y; Takenoshita S; Kuwano H; Yokota J Genomics; 1999 Oct; 61(1):5-14. PubMed ID: 10512675 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas. Manda R; Kohno T; Niki T; Yamada T; Takenoshita S; Kuwano H; Yokota J Biochem Biophys Res Commun; 2000 Aug; 275(2):440-5. PubMed ID: 10964684 [TBL] [Abstract][Full Text] [Related]
3. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display. Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881 [TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
6. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related]
7. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339 [TBL] [Abstract][Full Text] [Related]
8. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260 [TBL] [Abstract][Full Text] [Related]
9. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Taniwaki M; Daigo Y; Ishikawa N; Takano A; Tsunoda T; Yasui W; Inai K; Kohno N; Nakamura Y Int J Oncol; 2006 Sep; 29(3):567-75. PubMed ID: 16865272 [TBL] [Abstract][Full Text] [Related]
11. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490 [TBL] [Abstract][Full Text] [Related]
12. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814 [TBL] [Abstract][Full Text] [Related]
13. Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue. Schraml P; Shipman R; Colombi M; Ludwig CU Cancer Res; 1994 Oct; 54(19):5236-40. PubMed ID: 7923146 [TBL] [Abstract][Full Text] [Related]
14. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Xiang RH; Hensel CH; Garcia DK; Carlson HC; Kok K; Daly MC; Kerbacher K; van den Berg A; Veldhuis P; Buys CH; Naylor SL Genomics; 1996 Feb; 32(1):39-48. PubMed ID: 8786119 [TBL] [Abstract][Full Text] [Related]
15. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer. Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152 [TBL] [Abstract][Full Text] [Related]
16. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer. Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824 [TBL] [Abstract][Full Text] [Related]
17. Differentially expressed genes associated with human lung cancer. Xiao W; Pacyna-Gengelbach M; Schlüns K; An Q; Gao Y; Cheng S; Petersen I Oncol Rep; 2005 Jul; 14(1):229-34. PubMed ID: 15944794 [TBL] [Abstract][Full Text] [Related]
18. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. Yazawa T; Kamma H; Fujiwara M; Matsui M; Horiguchi H; Satoh H; Fujimoto M; Yokoyama K; Ogata T J Pathol; 1999 Jan; 187(2):191-9. PubMed ID: 10365094 [TBL] [Abstract][Full Text] [Related]
19. TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer. Wu WG; Soria JC; Wang L; Kemp BL; Mao L Anticancer Res; 2000; 20(6B):4525-9. PubMed ID: 11205299 [TBL] [Abstract][Full Text] [Related]
20. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]